BioNexus Gene Lab (BGLC) News
NASDAQ: BGLCHealth CareMedical SpecialitiesUSD
0.680.00 (0.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BGLC news summary
We found 2 recent headlines mentioning BioNexus Gene Lab (BGLC): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, BGLC is up 0.00% at $0.68. The most recent story, "BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific", was published by GlobeNewswire on Nov 3, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BioNexus Gene Lab headlines
- BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA ScientificBioNexus Gene Lab Corp. announces 1Lab Lab Management System integrated with GeneMatrixGlobeNewswire
- BioNexus Launches New Corporate Website with Expanded Business and Investor ResourcesBioNexus Gene Lab Corp. launches new websiteGlobeNewswire